Literature DB >> 34528026

Therapeutic Benefits from Nanoparticles: The Potential Significance of Nanoscience in Retinal Degenerative Diseases.

Raju V S Rajala1.   

Abstract

Several nanotechnology podiums have gained remarkable attention in the area of medical sciences, including diagnostics and treatment. In the past decade, engineered multifunctional nanoparticles have served as drug and gene carriers. The most important aspect of translating nanoparticles from the bench to bedside is safety. These nanoparticles should not elicit any immune response and should not be toxic to humans or the environment. Lipid-based nanoparticles have been shown to be the least toxic for in vivo applications, and significant progress has been made in gene and drug delivery employing lipid-based nanoassemblies. Several excellent reviews and reports discuss the general use and application of lipid-based nanoparticles; our review focuses on the application of lipid-based nanoparticles for the treatment of ocular diseases, and recent advances in and updates on their use.

Entities:  

Year:  2019        PMID: 34528026      PMCID: PMC8439377     

Source DB:  PubMed          Journal:  J Mol Biol Ther


  180 in total

1.  Evolutionary selection of new breast cancer cell-targeting peptides and phages with the cell-targeting peptides fully displayed on the major coat and their effects on actin dynamics during cell internalization.

Authors:  Gopal Abbineni; Sita Modali; Barbara Safiejko-Mroczka; Valery A Petrenko; Chuanbin Mao
Journal:  Mol Pharm       Date:  2010-08-25       Impact factor: 4.939

Review 2.  Histopathology of the human retina in retinitis pigmentosa.

Authors:  A H Milam; Z Y Li; R N Fariss
Journal:  Prog Retin Eye Res       Date:  1998-04       Impact factor: 21.198

3.  The origins of life: old problems, new chemistries.

Authors:  Stephen Mann
Journal:  Angew Chem Int Ed Engl       Date:  2012-12-03       Impact factor: 15.336

4.  Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy.

Authors:  Tian Fu; Jinglin Yi; Songyi Lv; Bing Zhang
Journal:  J Liposome Res       Date:  2016-09-07       Impact factor: 3.648

Review 5.  Neuroprotection by hypoxic preconditioning: HIF-1 and erythropoietin protect from retinal degeneration.

Authors:  C Grimm; D M Hermann; A Bogdanova; S Hotop; U Kilic; A Wenzel; E Kilic; M Gassmann
Journal:  Semin Cell Dev Biol       Date:  2005-04-18       Impact factor: 7.727

6.  Oxidative stress-induced retinal damage up-regulates DNA polymerase gamma and 8-oxoguanine-DNA-glycosylase in photoreceptor synaptic mitochondria.

Authors:  M Soledad Cortina; William C Gordon; Walter J Lukiw; Nicolas G Bazan
Journal:  Exp Eye Res       Date:  2005-06-24       Impact factor: 3.467

7.  Genomic DNA nanoparticles rescue rhodopsin-associated retinitis pigmentosa phenotype.

Authors:  Zongchao Han; Marcellus J Banworth; Rasha Makkia; Shannon M Conley; Muayyad R Al-Ubaidi; Mark J Cooper; Muna I Naash
Journal:  FASEB J       Date:  2015-02-24       Impact factor: 5.191

8.  Selective loss of S-cones in diabetic retinopathy.

Authors:  N C Cho; G L Poulsen; J N Ver Hoeve; T M Nork
Journal:  Arch Ophthalmol       Date:  2000-10

9.  Lutein and zeaxanthin protect photoreceptors from apoptosis induced by oxidative stress: relation with docosahexaenoic acid.

Authors:  Ana J Chucair; Nora P Rotstein; John Paul Sangiovanni; Alexandrine During; Emily Y Chew; Luis E Politi
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-11       Impact factor: 4.799

Review 10.  Viral and non-viral vectors in gene therapy: technology development and clinical trials.

Authors:  Kenneth Lundstrom; Teni Boulikas
Journal:  Technol Cancer Res Treat       Date:  2003-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.